Potent, selective and orally active 5-lipoxygenase inhibitor. ID50=0.8µM
Product Specification
Please mouse over
Product Literature References
Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor: R. Horrillo, et al.; J. Pharmacol. Exp. Ther.
323, 778 (2007),
Abstract;
Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation: L. Du, et al.; J. Biochem.
139, 715 (2006),
Abstract;
Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids: B.L. Diaz, et al.; J. Immunol.
168, 1397 (2002),
Abstract;